Inventor
CHAN TIN-YAU
US32 patents
⚠️ This page may combine multiple inventors who share the name “CHAN TIN-YAU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
9 patentsUS6914122B2Jul 5, 2005
Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties
SCHERING CORP89 citations95
US6900329B2May 31, 2005
MCH antagonists and their use in the treatment of obesity
SCHERING CORP18 citations92
US7700601B2Apr 20, 2010
Substituted indazoles of formula 1.0 that are kinase inhibitors
SCHERING CORP38 citations90
US7528132B2May 5, 2009
Kinase inhibitors
SCHERING CORP14 citations83
US7652020B2Jan 26, 2010
Compounds for the treatment of inflammatory disorders
SCHERING CORP5 citations62
US7452891B2Nov 18, 2008
MCH antagonists and their use in the treatment of obesity
SCHERING CORP0 citations52
US7807683B2Oct 5, 2010
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
SCHERING CORP0 citations51
US7595299B2Sep 29, 2009
Peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP0 citations51
US7514442B2Apr 7, 2009
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
SCHERING CORP1 citations51
DENDREON CORP
3 patentsUS7012066B2Mar 14, 2006
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP176 citations98
US7244721B2Jul 17, 2007
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP80 citations97
US7169760B2Jan 30, 2007
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP88 citations97
PHARMACOPEIA DRUG DISCOVERY
3 patentsUS7161003B1Jan 9, 2007
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PHARMACOPEIA DRUG DISCOVERY32 citations91
US7119200B2Oct 10, 2006
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PHARMACOPEIA DRUG DISCOVERY45 citations91
US7067661B2Jun 27, 2006
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PHARMACOPEIA DRUG DISCOVERY5 citations61